Search research articles
Contact Us
Filters
Showing results (81-90 of 85) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 85 results.
The Journal of Allergy and Clinical Immunology
|
February 9, 2023
SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity
Marco Rosichini, Veronica Bordoni, Domenico Alessandro Silvestris, et al.
Nature Communications
|
August 22, 2022
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
Alessandra Vergori, Alessandro Cozzi Lepri, Stefania Cicalini, et al.
International Immunopharmacology
|
January 20, 2025
Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients
Rita Casetti, Alessandra Sacchi, Valentina Mazzotta, et al.
Vaccines
|
July 27, 2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
Alessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 2, 2022
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
Andrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 85) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 85 results.
The Journal of Allergy and Clinical Immunology
|
February 9, 2023
SARS-CoV-2 infection of thymus induces loss of function that correlates with disease severity
Marco Rosichini, Veronica Bordoni, Domenico Alessandro Silvestris, et al.
Nature Communications
|
August 22, 2022
Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
Alessandra Vergori, Alessandro Cozzi Lepri, Stefania Cicalini, et al.
International Immunopharmacology
|
January 20, 2025
Innate and SARS-CoV-2 specific adaptive immune response kinetic in neutralizing monoclonal antibody successfully treated COVID-19 patients
Rita Casetti, Alessandra Sacchi, Valentina Mazzotta, et al.
Vaccines
|
July 27, 2024
Real World Use of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis of COVID-19 in Immunocompromised Individuals: Data from the OCTOPUS Study
Alessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 2, 2022
Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
Andrea Antinori, Stefania Cicalini, Silvia Meschi, et al.
Page
of 9